Your Voice Matters
Preserving Patient-centered Innovation
How Can You Get Involved?
Take action on important policy issues affecting all Americans.
The unique policy and regulatory framework in the United States supports innovation and access to medicines. It’s important that we protect it.
Diseases & Conditions
Take action to support policies that matter to you.
America depends on biopharmaceutical scientists to find treatments and cures aimed at improving quality of life for patients and loved ones.
Take action on issues relevant to your state.Stay informed and ready for action as state governments develop strategies to address today’s health care issues.
TAKE ACTION WITH OTHERS
Meet the patients and caregivers who are fighting to make medical innovation possible and accessible.
Caregiver to her son Matthew
Voters like Katie, a Georgia caregiver, overwhelmingly support solutions to help rein in insurance companies and their pharmacy benefit managers (PBMs). Join her in raising your voice to ensure that patients and doctors are the ones making decisions about medications, not PBMs who are more focused on bottom lines than quality of life.
Advocate and Retired Case Worker
Olga spent 10+ years working as a case worker, working specifically with minority women.In this role, Olga saw firsthand the power that innovation could bring to patients who needed it most. After the loss of her husband to brain cancer, Olga became committed to supporting and protecting medical innovation by advocating against legislation that could stifle the development of new, life-saving treatments.
Type 1 Diabetes Patient
Sue worries that more government control in the Medicare system will make it harder for her to access the medicines she needs.
Don’t let Congress jeopardize medical innovation.
Caregivers agree: tell Congress to support innovation
As a caregiver for her son Justin, Alisa holds onto hope for a cure for his rare disease, adrenoleukodystrophy, or ALD. Biopharmaceutical companies are working toward new treatments and a cure, but proposed government policies could delay this vital research. That’s why Alisa tells Congress to say no to price setting policies — because people with rare diseases don’t have time to jump through hoops. They need innovation, and quickly.